Trial Information

Summary: A Phase 1b Inpatient, Randomized, Double-Blind, Placebo-Controlled, Crossover Study of the Safety and Efficacy of Two Fixed Doses of XXXXXX in Adjunctive Treatment of Cognitive Deficits in Schizophrenia.

Currently Enrolling

Contact:

Lisa Wilkins
CRI Worldwide
130 White Horse Pike
Clementon, NJ 08021
Telephone: 877-993-2583 ext, 213
Fax: 856-566-9701
Email:

Profile Page: CRI Worldwide, Clementon, NJ

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:45:16 AM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA